153 related articles for article (PubMed ID: 3015008)
1. Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine.
Colacino J; Brownridge E; Greenberg N; Lopez C
Antimicrob Agents Chemother; 1986 May; 29(5):877-82. PubMed ID: 3015008
[TBL] [Abstract][Full Text] [Related]
2. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.
Colacino JM; Lopez C
Antimicrob Agents Chemother; 1985 Aug; 28(2):252-8. PubMed ID: 3010842
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
5. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
Kreis W; Damin L; Colacino J; Lopez C
Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
[TBL] [Abstract][Full Text] [Related]
8. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.
Colacino JM; Lopez C
Antimicrob Agents Chemother; 1983 Oct; 24(4):505-8. PubMed ID: 6316843
[TBL] [Abstract][Full Text] [Related]
10. Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.
Veerisetty V; Gentry GA
J Virol; 1983 Jun; 46(3):901-8. PubMed ID: 6304349
[TBL] [Abstract][Full Text] [Related]
11. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
12. Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity.
Veerisetty V; Balasubramaniam NK; Gentry GA
Acta Virol; 1990 Dec; 34(6):568-73. PubMed ID: 1983184
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
Chan PC; Wu CY; Chang WY; Chang WT; Alauddin M; Liu RS; Lin WJ; Chen FD; Chen CL; Wang HE
Nucl Med Biol; 2011 Oct; 38(7):987-95. PubMed ID: 21982570
[TBL] [Abstract][Full Text] [Related]
14. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
[TBL] [Abstract][Full Text] [Related]
15. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
Cheng YC; Dutschman G; Fox JJ; Watanabe KA; Machida H
Antimicrob Agents Chemother; 1981 Sep; 20(3):420-3. PubMed ID: 6272634
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125.
Perlman ME; Conti PS; Schmall B; Watanabe KA
Int J Nucl Med Biol; 1984; 11(3-4):215-8. PubMed ID: 6530342
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of DNA replication in herpes simplex virus infected cells by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine.
Allaudeen HS; Descamps J; Sehgal RK; Fox JJ
J Biol Chem; 1982 Oct; 257(20):11879-82. PubMed ID: 6288702
[No Abstract] [Full Text] [Related]
18. A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides.
Pizer LI; Mitchell DH; Bentele B; Betz JL
Int J Cancer; 1987 Jul; 40(1):114-21. PubMed ID: 3036717
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
Feinberg A; Leyland-Jones B; Fanucchi MP; Hancock C; Fox JJ; Watanabe KA; Vidal PM; Williams L; Young CW; Philips FS
Antimicrob Agents Chemother; 1985 May; 27(5):733-8. PubMed ID: 2990323
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
